JointGlow, a pioneer in non-surgical joint pain solutions, today announced a major clinical milestone: the delivery of over 1,600 Low-Dose Radiotherapy (LDRT) treatments to patients at its Orlando Orthopaedic Center location. This site stands as the first and only facility in the county to offer a fully integrated, multidisciplinary approach that embeds LDRT specialists directly within a premier orthopedic practice.
By combining advanced diagnostic imaging, surgical expertise, and specialized LDRT under one roof, JointGlow has created a seamless care corridor for patients suffering from chronic osteoarthritis, tendinopathies, and other inflammatory musculoskeletal (MSK) disorders. This collaborative model ensures that patients receive a comprehensive evaluation by orthopedic surgeons and pain specialists before being referred for LDRT as a highly effective, non-invasive alternative to surgery.
“Reaching the 1,600-treatment milestone at our Orlando Orthopaedic Center site validates the critical need for a bridge between conservative therapy and the operating room,” says Gokul Solai, M.D., founder and CEO of JointGlow. “By integrating LDRT into the orthopedic workflow, we’ve removed the silos of traditional medicine. Our patients benefit from a unified team that prioritizes preserving the natural joint, utilizing LDRT to deliver deep biological relief where injections and physical therapy have reached their limits.”
The success of the program underscores a growing shift in how chronic pain is managed in Central Florida. LDRT is a non-surgical, needle-free treatment that uses ultra-low levels of energy to modulate the inflammatory environment of a joint. For a vast majority of the patients treated, this intervention has significantly delayed or eliminated the need for invasive joint replacement surgery.
“Having LDRT available as a tool within our multidisciplinary setting allows us to optimize every stage of the patient journey,” added Dr. Solai. “Whether it is a golfer with chronic elbow tendinitis or a retiree with stage III knee osteoarthritis, our integrated approach ensures they receive the right treatment at the right time. This milestone is just the beginning of our mission to redefine what is possible in non-surgical orthopaedic care.”
JointGlow continues to expand its footprint in Florida, bringing this European standard of care to patients who are seeking long-term relief without the downtime of surgery or the side effects of chronic steroid use.
About JointGlow
JointGlow is a specialized medical practice dedicated to providing non-surgical, long-term relief for chronic joint and tissue pain through Low-Dose Radiotherapy (LDRT). By focusing on the biological root of inflammation, JointGlow offers an FDA-cleared, insurance-covered path to mobility for patients with osteoarthritis and MSK conditions.